Get started
Author

Leyla Özer

Observed names: L. Ozer, L. Özer, Leyla Ozer, Leyla Özer, Leyla ÖZER
Observed institutions: Acıbadem University, Sağlık Bilimleri Üniversitesi, Istanbul Memorial Hospital, Acıbadem University Atakent Hospital, İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi, Istanbul Arel University, Istanbul University
ORCID: 0000-0002-1430-2662
Observed ORCID: 0000-0002-1430-2662
OpenAlex ID: A5101413293
Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
2021 · Leyla Ozer, Ibrahim Yildiz, et al. · Colorectal Disease · 12
Current trends in perioperative treatment of resectable gastric cancer
2023 · İbrahim Yıldız, Leyla Özer, et al. · World Journal of Gastrointestinal Surgery · 10
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy
2017 · Ibrahim Yildiz, Ahmet Bilici, et al. · Tumori Journal · 10
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
2024 · Elif Şenocak Taşçı, Başak Oyan, et al. · BMC Cancer · 7
PDF
Aspirin resistance in patients with impaired renal functions
2013 · Hale Unal Aksu, Ender Oner, et al. · Kardiologia Polska · 7
PDF
Next-generation sequencing-based genomic profiling of advanced soft tissue and bone sarcomas
2025 · Yasemin Gündoğdu, Elif Şenocak Taşçı, et al. · Frontiers in Oncology · 6
PDF
Multi‐Institutional MR ‐Derived Radiomics to Predict Post‐Exenteration Disease Recurrence in Patients With T4 Rectal Cancer
2025 · Niall J. O'Sullivan, Fariba Tohidinezhad, et al. · Cancer Medicine · 4
PDF
Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial
2024 · Feride Yılmaz, Serkan Yaşar, et al. · Targeted Oncology · 4
Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases
2023 · Elif Şenocak Taşçı, İbrahim Yıldız, et al. · World Journal of Clinical Cases · 4
PDF
Intramural Component of Venous, Lymphatic, and Perineural Invasion in Colon Cancer: A Threat or an Illusion?
2022 · Leyla Özer, Elif Şenocak Taşçı, et al. · Balkan Medical Journal · 4
PDF
Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement
2022 · Erman Aytaç, Leyla Özer, et al. · The Turkish Journal of Gastroenterology · 4
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm
2023 · Melik Kagan Aktas, Erman Aytac, et al. · The Lancet Oncology · 3
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
2024 · Elif Şenocak Taşçı, Başak Oyan, et al. · BMC Cancer · 2
PDF
Case Report: Chemoimmunotherapy in microsatellite-instability-high advanced goblet cell carcinoma of the colon
2023 · Arda Ulaş Mutlu, Erman Aytaç, et al. · Frontiers in Immunology · 2
PDF
124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey
2021 · M.A.N. Sendur, B. Cakar, et al. · Annals of Oncology · 2
A Prodrome of Acute Lymphoblastic Leukemia Mimicking Sacroiliitis
2011 · Bahar Artım Esen, Leyla Özer, et al. · Electronic Journal of General Medicine · 2
PDF
Clinical course of a tailgut cyst transformed to retrorectal mucinous adenocarcinoma: A case report
2025 · Mirac Ajredini, Can Saracoglu, et al. · International Journal of Surgery Case Reports · 1
Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study.
2023 · Ece Esin, Melin Aydan Ahmed, et al. · Journal of Clinical Oncology · 1
PDF
Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDl-1 expression in Turkish patients with gastric cancer.
2019 · Ibrahim Yildiz, Seyma Bahsi, et al. · Journal of Clinical Oncology · 1
Clinicopathologic and molecular characteristics of colorectal cancer patients with brain metastases: a multicenter cohort study
2026 · Fatih Kemik, Bahadır Köylü, et al. · Scientific Reports
PDF
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
2026 · Zehra Sucuoğlu İşleyen, Şaban Seçmeler, et al. · BMC Cancer
Which patients with colorectal cancer develop brain metastases? A multicenter analysis of clinical and molecular predictors.
2026 · Fatih Kemik, Bahadır Köylü, et al. · Journal of Clinical Oncology
PDF
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program
2025 · Mehmet Ali Nahit Sendur, Mutlu Hizal, et al. · BMC Cancer
PDF
115P Changes in surgical and oncological characteristics of early-onset and late-onset colorectal cancers over five-year periods: A single-center 10-year experience
2025 · A.U. Mutlu, C. Saraçoglu, et al. · Annals of Oncology
PDF
AB089. SOH25_AB_124. Magnetic resonance-derived radiomics to predict post-exenteration disease recurrence in advanced rectal cancer: a multi-institutional analysis
2025 · Eimear Kyle, Niall O’Sullivan, et al. · Mesentery and Peritoneum
Works count: 40
Citation count: 86
H-index: 6
I10-index: 3
Year
Topic
Type